Design and synthesis of N-hydroxytriazole-4-carboxamides as HIV integrase inhibitors
Authors:
- 15 July 2014
- journal article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 24 (1) , 423-429
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitorsBioorganic & Medicinal Chemistry, 2012
- From Ligand to Complexes. Part 2. Remarks on Human Immunodeficiency Virus type 1 Integrase Inhibition by β-Diketo Acid Metal ComplexesJournal of Medicinal Chemistry, 2008
- Raltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infectionExpert Opinion on Investigational Drugs, 2007
- Efficient Conversion of Aromatic Amines into Azides: A One-Pot Synthesis of Triazole LinkagesOrganic Letters, 2007
- CuI‐Catalyzed Alkyne–Azide “Click” Cycloadditions from a Mechanistic and Synthetic PerspectiveEuropean Journal of Organic Chemistry, 2005
- Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus MacaquesScience, 2004
- HIV-1 Integrase Inhibitors: A Decade of Research and Two Drugs in Clinical TrialCurrent Topics in Medicinal Chemistry, 2004
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymesProceedings of the National Academy of Sciences, 2002
- Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in CellsScience, 2000